Status:
UNKNOWN
Pulmonary Rehabilitation of Patients With a History of COVID-19
Lead Sponsor:
University of Rzeszow
Conditions:
Covid19
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study will determine the impact of pulmonary rehabilitation on quality of life, body composition and respiratory function in patients with a history of COVID-19.
Detailed Description
In December 2019, a novel coronavirus, SARS-CoV-2, appeared, causing a wide range of symptoms, mainly respiratory infection. In March 2020, the World Health Organization (WHO) declared Coronavirus Dis...
Eligibility Criteria
Inclusion
- Male and female patients treated in Provincial Clinical Hospital No. 1 in Rzeszów/ Podkarpackie Center for Lung Diseases in Rzeszów,
- Patients with a history of COVID-19,
- Having obtained written informed consent (signed and dated) to participate in the study,
- Age at enrollment ≥ 18 years of age,
- No contraindications to pulmonary rehabilitation,
- No contraindications for body composition testing (bioelectrical impedance analysis).
Exclusion
- Refusal to participate in the study,
- Patients with any acute disease in the last 3 months before baseline,
- Patients currently enrolled in any clinical trial,
- Currently infected patients with COVID-19.
Key Trial Info
Start Date :
January 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 31 2021
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04751617
Start Date
January 1 2021
End Date
March 31 2021
Last Update
February 12 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Rzeszów / Podkarpackie Center for Lung Diseases in Rzeszów
Rzeszów, Poland, 35-959